IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on ...
Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback